Curis reported 6.6 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Amgen 18.6 0.53 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Bayer 4.61 0.47 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 64.5 31.61 Sep/2026
Exelixis 18.43 0.41 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Incyte 54.54 40.08 Sep/2026
Merck 34.36 2.11 Sep/2026
Novartis 19.17 3.24 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Takeda 21.04 3.36 Sep/2026
TG Therapeutics 75.56 55.92 Sep/2026